Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection.
Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial.
Virological rebound after suppression on highly active antiretroviral therapy.
A novel TaqMan real-time PCR assay to estimate ex vivo human immunodeficiency virus type 1 fitness in the era of multi-target (pol and env) antiretroviral therapy.
Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene Study.
Viral dynamics during structured treatment interruptions of chronic human immunodeficiency virus type 1 infection.
Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.
Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression.
Viral evolution during structured treatment interruptions in chronically human immunodeficiency virus-infected individuals.
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.